Vaccine and Treatment Evaluation Unit: Phase IV Clinical Trial to Evaluate Therapeutics for Community Acquired Pneumonia in Children

疫苗和治疗评估单位：评估儿童社区获得性肺炎治疗方法的 IV 期临床试验

• 批准号: 9925712
• 负责人: JENNIFER NIXON
• 金额: $ 110.01万
• 依托单位: VANDERBILT UNIVERSITY MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-04-25 至 2020-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9925712
• 关键词: Bacterial Drug Resistance; Child; Communicable Diseases; Communities; Conduct Clinical Trials; Contracts; Evaluation; Individual; Outpatients; Pediatrics; Phase IV Clinical Trials; Pneumonia; Population; Resources; Streptococcus pneumoniae; Therapeutic community technique; Vaccines; combat; design; named group; phase IV trial; programs

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations; however, access to special populations is also available.

该计划由学术中心和组织内部的个人合同组成，为设计和进行临床试验提供现成的资源，以评估抗击传染病的有前途的产品。一般来说，产品将在正常健康人群中进行评估；然而，也可以接触到特殊人群。